Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

Peripheral Intervention


News FDA updates stance on paclitaxel-coated devices to treat PAD
Product Serenity line extension: now available in 5–10 mm diameters to treat above the knee

Pioneers of peripheral medicine

Cook has worked alongside the pioneers of peripheral medicine for 60 years and remain dedicated to providing therapies and technologies that treat peripheral arterial and venous diseases. Globally, these impact millions of patients and require specialized devices and treatment options to improve patients’ quality of life.

Peripheral Arterial Disease (PAD) often occurs in the legs and can lead to amputation; those with the disease have a greater risk of suffering a heart attack or stroke.1 Cook provided the first drug-eluting-stent, Zilver® PTX®, has shown predictable results and is the only stent with published five-year data.2 Patients with PAD below the knee can be challenging to treat, our goal is to serve as a procedural partner in treating this disease. We have designed devices to increase efficiency, improve outcomes, and preserve limbs.

Venous disease is complex and can impact patients of younger and more diverse backgrounds than other vascular diseases. We are committed to helping all patients affected by deep venous disease by building awareness of the symptoms that can progress to pulmonary embolism or venous obstruction and developing therapies to treat them.

Cook delivers a comprehensive offering of introducer sets, wire guides, sheaths, catheters, balloons, and stents that enable physicians to effectively access, target, and treat these diseases. We offer a full line of filters and retrieval sets for the prevention of recurrent pulmonary embolism (PE).

  1. Facts about peripheral arterial disease (PAD). National Heart, Lung, and Blood Institute. NIH Publication No. 21-HL-5837; December 2021.
  2. Dake MD, Ansel GM, Jaff MR, et al. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation. 2016; 133(15):1472–1483.

 

Zilver PTX prediction model

Read More

Zilver PTX offers proven and predictable long-term results.

Read More

Healthcare inequities in PAD therapy

Read More

Limb preservation for BTK

Read More

Data shows Zilver Vena® benefits patients through three years.

Read More

Learn more about deep venous disease

Read More

Learn more about PE prevention

Read More

Fellows

Read More

Latest News


Study suggests effective treatment of symptomatic iliofemoral venous outflow obstruction1 The study, “Twelve-month end point results from the evaluation of the Zilver Vena venous stent in the treatment of symptomatic iliofemoral venous outflow obstruction (VIVO clinical study),” has shown that…

An interview with Dr. Eric Secemsky Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM Director of Vascular Intervention, Beth Israel Deaconess Medical Center Section Head, Interventional Cardiology and Vascular Research, Smith Center for Outcomes…

Cook’s 2nd generation CXI Support Catheter has earned its reputation as a premium technology for your procedural essentials in Peripheral Arterial Disease (PAD) cases. Cook Medical launched the new 2.6 Fr catheter on March 25, 2019, in the U.S. and…

Peripheral arterial disease (PAD) is a serious condition that affects 8-12 million Americans each year.1 PAD occurs when fatty deposits form in arteries that are outside of your heart. These fatty deposits (or plaque) can restrict the flow of blood.…

On March 25, Cook Medical launched the new 2.6 Fr CXI® Support Catheter with platinum-iridium marker bands. The new 2.6 Fr CXI, which is now available in the US and Canada, comes with additional tip configurations and a new 135…

Cook Medical is excited to invite you to attend a talk during the PAD Luncheon at VIVA 2018. Title: “The first DES gets the last word: unmatched evidence supports the first FDA-approved SFA drug-eluting stent” Topic covered: Understanding the basics of…

Visit our booth, #400, and come chat with us in our Cook Vascular Suite in Lafite 1. And we cordially invite you to attend our AORTIC Armageddon Luncheon and PAD Luncheon talks. AORTIC Armageddon Luncheon Title: “Achieving durable endovascular aortic…

Cook Medical is excited for VEINS at VIVA 2018. We hope you’ll visit our booth to learn what we’re up to in the world of venous endovascular interventional strategies. Stop by to chat with our staff and discuss all things…

September is Peripheral Artery Disease (PAD) Awareness Month. According to the CardioVascular Coalition, PAD affects approximately 18 million US citizens, and of those, an estimated 160,000 to 180,000 will have a limb amputated this year. Screening and treatment can “improve…

When Joe Roberts began working with venous therapies at Cook Medical, he never imagined that he would develop a deep vein thrombosis (DVT) himself. It's given him a heightened sense of purpose in letting others know about this potentially dangerous condition.

March is DVT Awareness Month. DVT (Deep Vein Thrombosis) can affect people of all ages and can be caused by circumstances that might not be considered as dangerous. Find out some facts that you may not know.

A tibiopedal approach showed 93.5% technical access success and 86.0% technical crossing success in a study sponsored by Cook Medical. Tibiopedal Access for Crossing of Infrainguinal Occlusions (TACO) is the world’s first multicenter, prospective, international study looking at success rates for…

Patients who suffer from peripheral arterial disease (PAD) will often initially visit a podiatrist, who may not be aware of the disease state. To address this educational gap, Peripheral Intervention is sponsoring round tables to help podiatrists learn more about PAD.

Bill Fischer, left, celebrates his 60th wedding anniversary with his wife, Barbara, right, their daughter, Gail McDaniel, and her partner, Keith Hamm. Bill underwent a surgical procedure to treat his advanced peripheral arterial disease. Knowing the symptoms of peripheral arterial…

Peripheral arterial disease (PAD) is a serious, underdiagnosed disease that is similar to coronary artery disease. Both develop when cholesterol levels and scar tissue build up, causing the arteries to narrow and restrict blood flow. The difference is that PAD…

The Centers for Disease Control and Prevention mapped the rapid growth of diabetes and obesity rates among Americans from 1994-2010. Diabetes and obesity are two of the main risk factors for peripheral arterial disease (PAD).   Learn more about PAD…

Peripheral arterial disease (PAD) is a common circulatory problem that affects the blood vessels outside of the heart and brain. It is usually caused by atherosclerosis, systemic plaque that results in a narrowing or clogging of the vascular system. PAD…

  Nelson L. Bernardo, MD, specializes in interventional cardiology and teaches a course for Vista on retrograde tibiopedal access. Dr. Bernardo is the medical director of the Peripheral Vascular Laboratory at MedStar Heart Institute. He is also the director for…

The proven technology of the Cook Celect® Vena Cava Filter is now improved with the addition of four platinum markers. The radiopaque markers on Celect® Platinum can help physicians verify placement accuracy immediately after filter detachment. Celect Platinum features leg struts…

Constantino S. Peña, MD, is an interventional radiologist with Miami Vascular Specialists in Miami, Florida. Dr. Peña received his medical degree from Yale University School of Medicine. He completed an internship in internal medicine at Yale-New Haven Hospital then completed…

Cook Medical is introducing the next-generation of a proven technology at the 2014 Annual Vascular Meeting of the Society for Vascular Surgery (SVS) and the SVS Foundation. Celect Platinum’s proven IVC filter is designed to enhance visibility. The specially designed…

The angiosome concept of perfusion delineates specific vascular territories that are supplied by specific arteries. The concept may help vascular interventionalists treat tissue defects caused by critical limb ischemia (CLI) by enabling the interventionalists to target arteries according to the…

Cook Medical's latest addition to its broad offering of wire guides is the Roadrunner® UniGlide.® The hydrophilic UniGlide offers a familiar feel and the performance physicians expect. A durable hydrophilic coating provides trackability and pushability, and a tungsten-impregnated jacket enhances visibility. A…

The CXI® Support Catheter is engineered for the periphery and can help you reach and cross lesions.CXI is now available in an .014 inch platform that features platinum-iridium marker bands for exceptional visibility. CXI’s stainless steel braid provides a 1:1 torque…

The Advance® 18LP Low-Profile PTA Balloon Dilatation Catheter is now available in nearly 200 size, length, and shaft configuration options. Additional balloon diameters are 2, 9, and 10 mm, while additional lengths are 12, 15, 17, and 20 cm. A catheter…

Dr. Larisee Lee, a physician from Southern California, talks about her experience attending a course through Cook Medical’s Vista℠Collaboration and Learning Program. We're confident you'll find an equally productive experience, whether you are just getting started or simply polishing your…
Load More Posts